Acevedo Medical Group

Miami, Florida 33142

0 studies enrolling now · 2 studies all time

What they study most

Attention Deficit Hyperactivity Disorder (ADHD)

Studies at this site

• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) — Stopped early
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years — Completed